Recent studies revealed that CXCR4 could enhance the acquisition of epithelial-to-mesenchymal transition (EMT-like) phenotype in MM cells, promoting extramedullary disease (EMD) development both in vivo and in vitro (40, 108). Here, CXCR4 is linked to Miyoshi myopathy.